Jiang Yici,Liu Ming.Clinical study on Shutiao Decoction based on psycho-cardiacology model in treating coronary heart disease with anxiety and depression[J].,2021,43(01):32-36.[doi:10.3760/cma.j.cn115398-20200421-00222]
基于“双心模式”的疏调汤治疗冠心病合并焦虑抑郁临床研究
- Title:
- Clinical study on Shutiao Decoction based on psycho-cardiacology model in treating coronary heart disease with anxiety and depression
- Keywords:
- Coronary Disease; Anxiety Disorders; Depression; Shutiao Decoction; Psychocardiology; Cooperative Behavior
- 摘要:
- 目的 评价疏调汤治疗冠心病合并焦虑抑郁患者的临床疗效。方法 将符合入选标准的2019年1－12月昆明市中医医院稳定性冠心病合并焦虑抑郁患者60例按随机数字表法分为2组，每组30例。对照组采用冠心病西医常规疗法联合心理干预，治疗组在对照组基础上服用疏调汤。2组均治疗4周。分别于治疗前后进行中医证候评分，采用西雅图心绞痛量表(Seattle Angina Questionnaiire, SAQ)评估患者生活质量及机体功能状态，采用汉密尔顿焦虑量表(Hamilton Anxiety Scale, HAMA)、汉密顿抑郁量表(Hamilton Depression Scale, HAMD)评估患者的焦虑、抑郁状态，评价临床疗效。结果 治疗组总有效率为90.0%(27/30)、对照组为73.3%(22/30)，2组比较差异有统计学意义(Z＝-2.515，P＝0.012)。治疗后，治疗组中医证候评分[(9.37±6.47)分比(18.37±6.58)分，t＝-5.341]低于对照组(P＜0.01)；SAQ量表中躯体活动受限程度、心绞痛稳定状态、心绞痛发作情况、治疗满意程度评分均高于对照组(t值分别为2.294、7.698、4.677、3.215，P＜0.05或P＜0.01)；HAMA[(9.20±5.26)分比(12.17±4.88)分，t＝-2.266]、HAMD[(11.27±5.83)分比(15.03±6.16)分，t＝-2.433]评分低于对照组(P＜0.05)。结论 疏调汤结合西医常规疗法及心理干预可有效改善冠心病合并焦虑抑郁患者生活质量及机体功能状态，提高临床疗效，改善心绞痛症状及焦虑、抑郁状态。
- Abstract:
- Objective To observe the clinical effect of Shutiao Decoction on patients with coronary heart disease and anxiety and depression. Methods Sixty patients with stable coronary artery disease and anxiety and depression from January 2019 to December 2019 in Kunming Municipal Hospital of Traditional Chinese Medicine were selected. They were divided into a treatment group of 30 cases and a control group of 30 cases according to random number table method. The control group recieved Western medicine routine treatment combined with psychological intervention, the treatment group was treated with Shutiao Decoction on the basis of the control group, and the treatment course of both groups was 4 weeks. Before and after treatment, TCM syndrome score, Seattle Angina Scale (SAQ), Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) were evaluated. The adverse events were recorded during treatment and clinical efficacy was evaluated. Results After treatment, the total effective rate in the treatment group was 90.0% (27/30), the control group was 73.3% (22/30), where the difference between the two groups was statistically significant (Z=-2.515, P=0.012). After treatment, the TCM syndrome score (9.37 ± 6.47 vs. 18.37 ± 6.58; t=-5.341, P<0.01) of the treatment group was significantly lower than that of the control group. Among SAQ domains’ scores, the physical activity limitation, and the stable state of angina pectoris, angina attack in the treatment group were significantly higher than those of the control group (t values were 2.294, 7.698, 4.677, 3.215, respectively, P<0.05 or P<0.01). The HAMA score of the treatment group was significantly lower than that of the control group (9.20 ± 5.26 vs. 12.17 ± 4.88; t=-2.266, P=0.027). The HAMD score in the treatment group was significantly lower than that of the control group (11.27 ± 5.83 vs. 15.03 ± 6.16; t=-2.433, P=0.018). During the treatment period, the incidence of adverse reactions was 3.33% (1/30) in the treatment group and 6.67% (2/30) in the control group. There was no statistically significant difference between the two groups (χ2=0.351, P=0.554). Conclusion Shutiao Decoction combined with western medicine routine treatment can improve patients’ TCM syndromes, relief angina pectoris, anxiety and depression.
参考文献/References:
［1］ Roest AM,Martens EJ,de Jonge P,et al. Anxiety and risk of incident coronary heart disease:a meta-analysis[J]. J Am Coll Cardiol,2010,56(1):38-46. DOI:10.1016/j.jacc.2010.03.034. ［2］ 周洪丹,邹晓昭,刘乐,等. 冠心病患者经皮冠状动脉介入术后焦虑抑郁现状及影响因素分析[J]. 心肺血管病杂志,2019, 38(4):356-359,369. DOI:10.3969/j.issn.1007-5062.2019.04.008. ［3］ Nicholson A,Kuper H,Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease:a meta-analysis of 6362 events among 146 538 participants in 54 observational studies[J]. Eur Heart J,2006,27(23):2763-2774. DOI:10.1093/eurheartj/ehl338. ［4］ Whooley MA,de Jonge P,Vittinghoff E,et al. Depressive symptoms,health behaviors,and risk of cardiovascular events in patients with coronary heart disease[J]. JAMA,2008,300(20): 2379-2388. DOI:10.1001/jama.2008.711. ［5］ 中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694. DOI:10.3760/cma.j.issn.0253-3758.2018.09.004. ［6］ 中华医学会精神科分会. 中国精神障碍分类与诊断标准[M]. 3版. 济南:山东科学技术出版社,2001:80-88. ［7］ 郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002:69-73. ［8］ 周仲瑛. 中医内科学[M]. 2版. 北京:中国中医药出版社, 2011:137-139. ［9］ 刘淑红. 西雅图心绞痛量表(SAQ)中文译本的信度、效度、反应度[D]. 天津:天津医科大学,2003. ［10］ 张作记,王长谦,崔立谦. 冠心病患者生活质量的评价、影响因素及其干预[J]. 中国行为医学科学,1998,7(4):309-311,314. ［11］ 张明园,何燕玲. 精神科评定量表手册[M]. 长沙:湖南科学技术出版社,2015:143-181. ［12］ 张亦舒. 张震:提高疗效 勿忘疏调气机[N]. 中国中医药报, 2017-12-08(004).
相似文献/References:
[1]郑信团 孙海花 凃人顺 孙淑菊 王宪举.健身气功六字诀对中老年轻度焦虑症康复作用的研究[J].国际中医中药杂志,2012,34(04):299.[doi:10.3760/cma.j.issn.1673-4246.2012.04.004]
ZHENG Xin-tuan,SUN Hai-hua,TU Ren-shun,et al.Rehabilitation of “Six Healing Sounds”on anxiety disorders of the old and middle-aged persons[J].,2012,34(01):299.[doi:10.3760/cma.j.issn.1673-4246.2012.04.004]
[2]路继刚.炙甘草汤加减治疗老年冠心病的临床研究[J].国际中医中药杂志,2015,37(09):800.[doi:10.3760/cma.j.issn.1673-4246.2015.09.009]
Lu Jigang..Clinical study on Zhigancao decoction for the treatment of senile coronary heart disease [J].,2015,37(01):800.[doi:10.3760/cma.j.issn.1673-4246.2015.09.009]
[3]陈婷 胡明露 赵稼萤.通痹汤对冠心病心绞痛患者内皮功能及血液流变学的影响[J].国际中医中药杂志,2019,41(2):120.[doi:10.3760/cma.j.issn.1673-4246.2019.02.004]
Chen Ting,Hu Minglu,Zhao Jiaying.Effect of Tongbi decoction on endothelial function and hemorheology in patients with coronary heart disease with angina pectoris[J].,2019,41(01):120.[doi:10.3760/cma.j.issn.1673-4246.2019.02.004]
[4]夏鸣华 刘晓伟 朱华 季向东.九味镇心颗粒联合盐酸丁螺环酮片治疗老年期焦虑症临床研究[J].国际中医中药杂志,2019,41(11):1170.[doi:10.3760/cma.j.issn.1673-4246.2019.11.004]
Xia Minghua,Liu Xiaowei,Zhu Hua,et al.Research on the clinical effect of Jiuwei-Zhenxin granules and buspirone hydrochloride tablets for geriatric anxiety patients[J].,2019,41(01):1170.[doi:10.3760/cma.j.issn.1673-4246.2019.11.004]
[5]李艳 金敏 杨羽.柴胡龙骨牡蛎汤联合西医常规疗法治疗躯体性焦虑症临床研究[J].国际中医中药杂志,2019,41(12):1314.[doi:10.3760/cma.j.issn.1673-4246.2019.12.008]
Li Yan,Jin Min,Yang Yu.Clinical study of Chaihu-Longgu-Muli decotion combined with western medicine in the treatment of somatic anxiety disorder [J].,2019,41(01):1314.[doi:10.3760/cma.j.issn.1673-4246.2019.12.008]
备注/Memo
通信作者：刘明，Email: 18210017375@163com
更新日期/Last Update:
2021-01-05